Area of activity

Chronic kidney disease (CKD) is a health problem affecting millions of people, in Poland, the number of patients is estimated at approximately 4.2 million. At our company, we place great emphasis on bringing innovative products related to the treatment of CKD to market for several key reasons.

CKD, although relatively easy to diagnose, often goes unnoticed and untreated, leading to serious health consequences. Our main goal is to focus on early diagnosis, and the innovative therapies we introduce enable effective disease management, thus delaying the need for renal replacement therapy.

In addition to health aspects, the development of CKD also generates significant treatment costs, estimated at almost PLN 2 billion per year. By introducing modern therapeutic solutions, we want not only to reduce the financial burden on the health system but also to provide more effective treatment methods.

By introducing innovative products related to the treatment of CKD, our company not only responds to the urgent health needs of society but also actively strives to change the face of care for nephrology patients in Poland, emphasizing prevention, early intervention, and improving the quality of life.

Heart failure (HF) is a priority health challenge, being the main cause of death due to cardiovascular diseases in Poland. It is a complex clinical syndrome characterized by symptoms caused by structural or functional abnormalities of the heart. It includes high morbidity, hospitalizations, and increased mortality. In Poland, before the COVID-19 pandemic, the number of HF patients was systematically increasing, reaching over 125,000 per year, with an increasing cost burden. Currently, despite the decline in diagnosis due to the pandemic, the number of deaths due to HF reaches almost 150,000 annually. This poses a challenge for healthcare systems, especially in the context of an aging population and increasing life expectancy.

In response to these challenges, proposed strategies to improve the care of patients with HF include dedicated care models such as case management, disease management, and clinical pathway management. Early diagnosis is crucial for effective long-term care, bringing lower costs and reducing the risk of complications. Patients with HF require constant medical care, access to modern therapies, rehabilitation, and palliative care.

Technological development enables effective management of HF using telemedicine solutions and monitoring. There is a need to create an integrated model of care for patients with HF in Poland, including the continuity of outpatient and hospital care. A key element is the cooperation of multidisciplinary teams and improved communication between patients and doctors.

In light of the growing importance of HF, our product portfolio efforts focus on providing innovative diagnostic, therapeutic, and monitoring solutions. We strive to improve health care standards by paying attention to patient needs, reducing diagnosis times, and providing comprehensive care to effectively manage heart failure.

Heart rhythm disturbances, also known as arrhythmias, are a significant health challenge that affects millions of people around the world. This is a wide spectrum of problems, including rapid heartbeat (tachycardia), too-slow heartbeat (bradycardia), and irregular rhythms. These are issues that have a significant impact on the quality of life of patients and require specialized attention.

In our approach to creating a product offer, we place particular emphasis on understanding and solving these problems. Heart rhythm disturbances can lead to serious health consequences, including an increased risk of stroke, heart failure, or even sudden cardiac arrest. Therefore, our products not only allow for effective diagnosis but also offer innovative therapeutic solutions.

We realize that effective care for patients with heart rhythm disorders is not only a matter of treatment but also of support and education. Our product offering is constantly evolving to meet the dynamic challenges of arrhythmias. We introduce modern technologies and strive to constantly improve our solutions.

We believe that building a comprehensive product offer that includes diagnosis, therapy and long-term care is crucial to improving the quality of life of patients with heart rhythm disorders. Our goal is not only to treat conditions but also to create innovative tools that enable the tracking and management of arrhythmias, contributing to the heart health and overall well-being of our patients.

In health care, each hospital is a gigantic machine that sometimes seems uncontrollable. This is a unique challenge for management staff, balancing the demands of economic calculations with the absolute obligation to help patients. When solving one problem, we often encounter new ones. A limited budget and complex regulations do not always make it easier to make optimal decisions.

In our company, we approach this challenge with determination. We are looking for innovative solutions that support effective hospital management, enabling it to function optimally. Our goal is to encourage healthcare units to use available resources more effectively. By promoting modern technological solutions, we want to prove that every aspect of hospital functioning can be redefined and made more effective.

Increasing financing of the health service is an important demand, but we realize that without simultaneous improvement of processes, it is only a half-measure. Optimizing hospital operations directly translates into the quality of healthcare provided, which in turn affects the experience of patients - all of us. We believe that striving for a balance between operational efficiency and high-quality healthcare is the key to the future of healthcare.

Wspólnie zadbajmy o zdrowie oraz bezpieczeństwo Waszych pacjentów!

© 2024 Certmed Sp. z o.o.. Design and implementation